Free Trial

Evommune (EVMN) Institutional Ownership

Evommune logo
$19.83 -0.86 (-4.16%)
Closing price 03:59 PM Eastern
Extended Trading
$19.70 -0.13 (-0.68%)
As of 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Evommune (NYSE:EVMN)

Number of
Institutional Buyers
(last 12 months)
43
Total
Institutional Inflows
(last 12 months)
$426.89M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$8.28M
Get EVMN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Evommune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

EVMN Institutional Buying and Selling by Quarter

Evommune Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/12/2026 Defilade Capital Management L.P.678,589$15.60M2.2%+215.0%1.884%
5/29/2026 Perceptive Advisors LLC448,350$10.31M0.2%N/A1.245%
5/19/2026 Bank of America Corp DE30,201$694K0.0%+928.3%0.084%
5/19/2026 Stempoint Capital LP193,777$4.39M0.8%+184.1%0.538%
5/19/2026 Janus Henderson Group PLC896,700$20.62M0.0%N/A2.489%
5/18/2026 Eversept Partners LP54,680$1.26M0.1%N/A0.152%
5/16/2026 The Manufacturers Life Insurance Company 12,812$295K0.0%+25.3%0.036%
5/15/2026 Octagon Capital Advisors LP143,472$3.30M0.4%-71.3%0.398%
5/14/2026 Monashee Investment Management LLC179,340$4.12M2.2%-2.1%0.498%
5/5/2026 Bank of New York Mellon Corp22,091$508K0.0%N/A0.061%
4/25/2026 Strs Ohio1,800$41K0.0%N/A0.005%
2/18/2026 XTX Topco Ltd18,778$321K0.0%N/A0.060%
2/18/2026 Tudor Investment Corp ET AL31,953$547K0.0%N/A0.101%
2/18/2026 Sphera Funds Management LTD.166,147$2.84M0.5%N/A0.527%
2/18/2026 RTW Investments LP1,283,671$21.98M0.2%N/A4.073%
2/18/2026 Oxford Asset Management LLP19,565$335K0.1%N/A0.062%
2/18/2026 Balyasny Asset Management L.P.65,000$1.11M0.0%N/A0.206%
2/17/2026 ADAR1 Capital Management LLC184,062$3.15M0.2%N/A0.584%
2/17/2026 Burkehill Global Management LP50,000$856K0.1%N/A0.159%
2/17/2026 MPM Bioimpact LLC113,022$1.94M0.2%N/A0.359%
2/17/2026 RA Capital Management L.P.3,458,770$59.21M0.6%N/A10.973%
2/17/2026 Price T Rowe Associates Inc. MD782,121$13.39M0.0%N/A2.481%
2/17/2026 Integral Health Asset Management LLC125,000$2.14M0.1%N/A0.397%
2/16/2026 Sofinnova Investments Inc.153,320$2.63M0.1%N/A0.486%
2/16/2026 Verition Fund Management LLC565,214$9.68M0.0%N/A1.793%
2/16/2026 NEXTBio Capital Management LP228,286$3.91M2.3%N/A0.724%
2/16/2026 Nan Fung Group Holdings Ltd1,441,032$24.67M22.1%N/A4.572%
2/16/2026 Eventide Asset Management LLC961,525$16.46M0.3%N/A3.051%
2/13/2026 Marshall Wace LLP988,200$16.92M0.0%N/A3.135%
2/13/2026 The Manufacturers Life Insurance Company 10,225$179K0.0%N/A0.032%
2/13/2026 Pivotal bioVenture Partners Investment Advisor LLC1,926,943$32.99M12.8%N/A6.113%
2/13/2026 Velan Capital Investment Management LP506,754$8.68M5.0%N/A1.608%
2/13/2026 Charles Schwab Investment Management Inc.62,704$1.07M0.0%N/A0.199%
2/13/2026 State Street Corp31,500$539K0.0%N/A0.100%
2/12/2026 Federated Hermes Inc.325,000$5.56M0.0%N/A1.031%
2/12/2026 SymBiosis Capital Partners LLC1,280,778$21.93M21.1%N/A4.063%
2/12/2026 Monashee Investment Management LLC183,239$3.14M1.8%N/A0.581%
2/11/2026 EQT Fund Management S.a r.l.4,929,633$84.40M7.6%N/A15.638%
2/11/2026 JPMorgan Chase & Co.1,308,901$22.41M0.0%N/A4.152%
2/10/2026 TD Asset Management Inc44,634$764K0.0%N/A0.142%
Is SpaceX really worth 1.78 Trillion? (Ad)

With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analyst Lance Ippolito says the real opportunity is elsewhere. He's identified 5 dirt-cheap stocks at the forefront of this mega-IPO, including a space ticker that Goldman Sachs, BlackRock, and Morgan Stanley are all buying, a rare resource miner Elon's entire empire depends on, and the chip supplier Starlink satellites can't function without. Access his free SpaceX Investing Blackbook before IPO day arrives.tc pixel

Get the free SpaceX Investing Blackbook and see all 5 names
2/10/2026 Goldman Sachs Group Inc.61,675$1.06M0.0%N/A0.196%
2/10/2026 Seven Grand Managers LLC75,000$1.28M0.1%N/A0.238%
2/9/2026 Geode Capital Management LLC109,781$1.88M0.0%N/A0.348%
2/9/2026 Sectoral Asset Management Inc.589,005$10.08M8.0%N/A1.869%
1/29/2026 China Universal Asset Management Co. Ltd.2,000$34K0.0%N/A0.006%
1/21/2026 Capricorn Fund Managers Ltd60,000$1.03M0.2%N/A0.190%


EVMN Institutional Ownership - Frequently Asked Questions

During the previous two years, 44 institutional investors and hedge funds held shares of Evommune. The most heavily invested institutionals were EQT Fund Management S.a r.l. ($84.40M), RA Capital Management L.P. ($59.21M), Pivotal bioVenture Partners Investment Advisor LLC ($32.99M), Nan Fung Group Holdings Ltd ($24.67M), JPMorgan Chase & Co. ($22.41M), RTW Investments LP ($21.98M), and SymBiosis Capital Partners LLC ($21.93M).Learn more on Evommune's institutional investors.

Of the 43 institutional investors that purchased Evommune's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: EQT Fund Management S.a r.l. ($4.93M), RA Capital Management L.P. ($3.46M), Pivotal bioVenture Partners Investment Advisor LLC ($1.93M), Nan Fung Group Holdings Ltd ($1.44M), JPMorgan Chase & Co. ($1.31M), RTW Investments LP ($1.28M), and SymBiosis Capital Partners LLC ($1.28M).

Institutional investors have bought a total of 24,185,662 shares in the last 24 months. This purchase volume represents approximately $426.89M in transactions.

The following institutional investors have sold Evommune stock in the last 24 months: Octagon Capital Advisors LP ($356.53K), and Monashee Investment Management LLC ($3.90K).

Institutional investors have sold a total of 360,427 shares in the last 24 months. This volume of shares sold represents approximately $8.28M in transactions.



This page (NYSE:EVMN) was last updated on 6/12/2026 by MarketBeat.com Staff.
From Our Partners